Ensysce Biosciences (ENSCW) Long-Term Investments (2017 - 2021)

Ensysce Biosciences (ENSCW) has 5 years of Long-Term Investments data on file, last reported at $12.7 million in Q1 2021.

• Long-Term Investments for Q1 2021 came in at $12.7 million, down 79.31% year-over-year; the trailing twelve-month figure through Mar 2021 was $12.7 million (down 79.31% YoY), and the FY2020 annual result was $12.6 million, down 93.53% from the prior year.
• Long-Term Investments held at $12.7 million in Q1 2021 per ENSCW's latest filing, from $12.6 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $205.8 million in Q3 2019 and troughed at $12.6 million in Q4 2020.
• A 5-year average of $137.9 million and a median of $200.4 million in 2017 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2019 and 2020: Long-Term Investments grew 1.82% in 2019, then slumped 93.59% in 2020.
• A 5-year view of Long-Term Investments shows it stood at $200.1 million in 2017, then rose by 1.4% to $202.9 million in 2018, then decreased by 3.75% to $195.3 million in 2019, then tumbled by 93.53% to $12.6 million in 2020, then gained by 0.5% to $12.7 million in 2021.
• Business Quant data shows ENSCW's Long-Term Investments at $12.7 million in Q1 2021, $12.6 million in Q4 2020, and $13.2 million in Q3 2020.